Banti's syndrome: Difference between revisions

	WikiDoc Resources for Banti's syndrome
Articles
Most recent articles on Banti's syndrome Most cited articles on Banti's syndrome Review articles on Banti's syndrome Articles on Banti's syndrome in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Banti's syndrome Images of Banti's syndrome Photos of Banti's syndrome Podcasts & MP3s on Banti's syndrome Videos on Banti's syndrome
Evidence Based Medicine
Cochrane Collaboration on Banti's syndrome Bandolier on Banti's syndrome TRIP on Banti's syndrome
Clinical Trials
Ongoing Trials on Banti's syndrome at Clinical Trials.gov Trial results on Banti's syndrome Clinical Trials on Banti's syndrome at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Banti's syndrome NICE Guidance on Banti's syndrome NHS PRODIGY Guidance FDA on Banti's syndrome CDC on Banti's syndrome
Books
Books on Banti's syndrome
News
Banti's syndrome in the news Be alerted to news on Banti's syndrome News trends on Banti's syndrome
Commentary
Blogs on Banti's syndrome
Definitions
Definitions of Banti's syndrome
Patient Resources / Community
Patient resources on Banti's syndrome Discussion groups on Banti's syndrome Patient Handouts on Banti's syndrome Directions to Hospitals Treating Banti's syndrome Risk calculators and risk factors for Banti's syndrome
Healthcare Provider Resources
Symptoms of Banti's syndrome Causes & Risk Factors for Banti's syndrome Diagnostic studies for Banti's syndrome Treatment of Banti's syndrome
Continuing Medical Education (CME)
CME Programs on Banti's syndrome
International
Banti's syndrome en Espanol Banti's syndrome en Francais
Business
Banti's syndrome in the Marketplace Patents on Banti's syndrome
Experimental / Informatics
List of terms related to Banti's syndrome

VisualWikitext

Revision as of 23:02, 28 January 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Template:Your Name

Overview

Historical Perspective

Banti's syndrome was first described in 1883 by Dr. Banti, an Italian physycian. He described a case series of patients probably exposed to an unknown toxin leading to chronic spleen and liver injury. Patients were developing chronic splenomegaly followed by secondary hypochromic anemia. The disease progressed to advanced stages and manifested by hemorrhages from gastrointestinal tract, ascites, and advanced liver injury and cirrhosis.
The most important pathologic finding in Banti's syndrome is called "fibro-ad\l=e'\nie"in the splenic white pulp or splenic lymphoid nodules
- This process involves having its inception around the splenic penicillate arteries.
Osler support and further defined Banti's concept of the disease. He defined the diseaseas: "An intoxication of unknown nature characterized by great chronicity. There is a preliminary progressive enlargement of the spleen which cannot be correlated with any known cause, anemia of secondary type with leukopenia, a marked tendency to hemorrhage from the lower esophagus, and a terminal state with cirrhosis of the liver."

The disease got further attention and other physicians explained an association between splenomegaly and secondary anemia with splenic or the portal vein thrombosis.
Cauchois, Warthin, Eppinger, and Klemperer further explored the disease and showed that the thrombosis is the main cause of the splenomegaly.
Larrabee evaluated forty seven cases of Banti's syndrome and concluded the main clinical symptoms of Banti's syndrome is dependent on intra-abdominal lesion obstructing the venous outflow of the spleen.He notices that liver cirrhosis is the most common cause of splenic venous outflow obstruction. He suggested the use of term "chronic congestive splenomegaly" as an alternative name for "Banti's syndrome".
Rousselot was the one who brought attention to the gross pathology of portal veins when a splenectomy was being performed on patients with Banti's disease. The gross pathology of portal veins showing dilated and tortuous veins in the splenic pedicle, leading to dilation of slenic collateral circulation. As there was enormous adhesion around the spleen, splenectomy was a dangerous procedure for these patients.
Thompson explained similarities in the microscopic pathology of spleen in patients with Banti's syndrome, characterized by:
- Variable degrees of follicular atrophy
- Fibrosis of the white pulp
- Dilated venous sinuses
- Perifollicular hemorrhages
He described the obstructive lesions as being either intrahepatic or extrahepatic.
- The intrahepatic lesion was defined to be cirrhosis and contained 68% of the cases that has undergone splenectomy.
Thompson and his associates shave made observations on the splenic vein pressure in fifteen cases in the course of operation by inserting the needle of the venous pressure apparatus into the splenic vein. The relatively great increase in splenic pressure in cases of Banti's syndrome when compared with the venous pressure simultaneously recorded in the arm suggests that portal hypertension is an important factor in the production of the chronic splenomegaly. The contention of the workers of the Combined Spleen Clinic is that Banti's disease or splenic anemia is a secondary mechanical manifestation of any of a variety of lesions producing chronic splenic vein hypertension. They therefore suggest that the terms Banti's disease and splenic anemia be replaced by congestive splenomegaly, as originally suggested by Larrabee. The type of liver cirrhosis in prolonged schistosomiasis results in the greatest increase in portal pressure and the largest spleens. The behavior of this parasitic disease is ideal for the production of portal hypertension.
Campbell was working on cases with schistosomiasis in the Orient. He described schistosomiasis as the main cause of the manifestations of Banti's syndrome. He believed that as most of the cases were observed by Banti in Italy, and based on the geographical proximity of Italy to Egypt which is considered as high prevalent area for schistosomiasis , probably the schistasomiasis is the main reason of the disease.

Template:WH Template:WS

@@ Line 7: / Line 7: @@
 ==Historical Perspective==
-In 1883 Banti described a group of cases characterized by primary enlargement of the spleen, a more or less characteristic secondary hypochromic anemia and a chronic course. The disease passed through typical stages characterized in its advanced stage by hemorrhages from the gastrointestinal tract, ascites and terminal liver cirrhosis. The causative factor was an unknown toxin which acted primarily on the spleen and secondarily on the liver. The essential and distinctive pathologic feature of the spleen was "fibro-ad\l=e'\nie"in the malpighian bodies, the process having its inception around the penicillate arteries. This concept received its support from Osler, who defined the new disease entity as follows : "An intoxication of unknown nature characterized by great chronicity. There is a preliminary progressive enlargement of the spleen which cannot be correlated with any known cause, anemia of secondary type with leukopenia, a marked tendency to hemorrhage from the lower esophagus, and a terminal state with cirrhosis of the liver."
-The idiopathic nature of Banti's disease soon came into question. Numerous observations appeared demonstrating that splenomegaly and secondary anemia were associated with thrombosis of the splenic or the portal vein. Cauchois 1 collected reports of a number of cases, including his own, of splenomegaly and anemia of pylethrombotic origin. He emphatically refuted Banti's concept. Warthin 2 concluded on the basis of several observations that "every factor of the symptom complex that Osier lays down as the criterion for splenic anemia is also a factor in the complex of portal sclerosis and thrombosis." Eppinger in his classic treatise on hepatolienal diseases devotes a chapter to the relationship between portal congestion and splenomegaly. Klemperer 3 reported a case of cavernomatous transformation of the portal vein presenting clinical and pathologic characteristics corresponding in all respects to that of Banti's. Larrabee,4 on the basis of a study of fortyseven cases, concluded that in the majority of cases presenting the clinical picture of Banti's disease the condition is dependent on some intra-abdominal lesion
+* Banti's syndrome was first described in 1883 by Dr. Banti, an Italian physycian. He described a case series of patients probably exposed to an unknown toxin leading to chronic spleen and liver injury. Patients were developing chronic splenomegaly followed by secondary hypochromic anemia. The disease progressed to advanced stages and manifested by hemorrhages from gastrointestinal tract, ascites, and advanced liver injury and cirrhosis.
+* The most important pathologic finding in Banti's syndrome is called "fibro-ad\l=e'\nie"in the splenic white pulp or splenic lymphoid nodules
+** This process involves having its inception around the splenic penicillate arteries.
+* Osler support and further defined Banti's concept of the disease. He defined the diseaseas: "An intoxication of unknown nature characterized by great chronicity. There is a preliminary progressive enlargement of the spleen which cannot be correlated with any known cause, anemia of secondary type with leukopenia, a marked tendency to hemorrhage from the lower esophagus, and a terminal state with cirrhosis of the liver."
-obstructing the venous outflow of the spleen. The commonest of these was liver cirrhosis. He states that "we are forced to the conclusion that most if not all of these cases were not only associated with lesions interfering with the outflow of blood from the spleen but were actually the results of such lesions." .Larrabee suggested that the syndrome be referred to as chronic congestive splenomegaly. Johnston,5 in his study on the relative size of the hepatic portal radicles in splenic anemia and Banti's disease, concluded "We are dealing here with mechanical alterations of the portal blood flow interfering with the free exit of blood from the spleen." Interesting contributions have recently come from he Combined Spleen Clinic at the Presbyterian Hospital, New York. Rousselot6 calls attention to the fact that the appearance of the portal circulation in the course of a splenectomy for Banti's disease is at once indicative of portal hypertension. This dilated and tortuous collection of veins in the splenic pedicle and the enormously dilated veins of the large collateral circulation in the adhesions surrounding the spleen make the removal of the spleen in these cases a formidable and hazardous procedure. This local vascular condition, Rousselot points out, was present regardless of the nature of the "obstructive factor." Microscopic examination of the removed spleens revealed the essential similiarity of the changes in the various cases. Thompson of the same clinic sums up the experience of the clinic comprising 137 cases observed in the past ten years. Of this group 100 cases had been followed under nearly ideal circumstances for clinical investigation. Splenectomies were done in sixty-eight cases. The cases were those of splenomegaly with anemia, leukopenia and thrombocytopenia, development of increased collateral circulation between the portal and peripheral venous circulation and microscopic changes in the spleen that are characteristic. The result of this study is a refutation of Banti's concept. Thompson states "It is our current concept that Banti's disease or splenic anemia is the result of mechanical obstruction to the flow of blood within the portal system. With high portal pressure and relatively low peripheral pressure a reversal in the direction of normal blood flow can take place. This reversal is aided by the absence of valves in the portal system. A careful study of our clinical material leads to the conclusion that there are no significant differences clinically or hematologically between the congestive splenomegalies resulting from the various obstructive factors."
+* The disease got further attention and other physicians explained an association between splenomegaly and secondary anemia with splenic or the portal vein thrombosis.
+* Cauchois, Warthin, Eppinger, and Klemperer further explored the disease and showed that the thrombosis is the main cause of the splenomegaly.
-The histologie characteristics of the removed spleens were the same in all groups. All presented variable degrees of follicular atrophy, of fibrosis of the pulp with dilated venous sinuses, and all had the characteristic perifollicular hemorrhages. The obstructive lesions are either intrahepatic or extrahepatic. The intrahepatic lesion is cirrhosis; indeed, hepatic cirrhosis was the obstructive factor in 68 per cent of the cases. Rousselot and Thompson injected silica particles into the splenic veins of dogs and produced after two years a congestive splenomegaly with extensive collateral circulation. Thompson emphasizes that absence of cirrhosis as the obstructive agent at the time of splenectomy means that it will not appear subsequently. Thus he says "We have yet to see a patient develop the sequence of events characterized by Banti as the three stages of the syndrome."
+* Larrabee evaluated forty seven cases of Banti's syndrome and concluded the main clinical symptoms of Banti's syndrome is dependent on intra-abdominal lesion obstructing the venous outflow of the spleen.He notices that liver cirrhosis is the most common cause of splenic venous outflow obstruction. He suggested the use of term "chronic congestive splenomegaly" as an alternative name for "Banti's syndrome".
+* Rousselot was the one who brought attention to the gross pathology of portal veins when a splenectomy was being performed on patients with Banti's disease. The gross pathology of portal veins showing dilated and tortuous veins in the splenic pedicle, leading to dilation of slenic collateral circulation. As there was enormous adhesion around the spleen, splenectomy was a dangerous procedure for these patients.
-Thompson and his associates shave made observations on the splenic vein pressure in fifteen cases in the course of operation by inserting the needle of the venous pressure apparatus into the splenic vein. The relatively great increase in splenic pressure in cases of Banti's syndrome when compared with the venous pressure simultaneously recorded in the arm suggests that portal hypertension is an important factor in the production of the chronic splenomegaly. The contention of the workers of the Combined Spleen Clinic is that Banti's disease or splenic anemia is a secondary mechanical manifestation of any of a variety of lesions producing chronic splenic vein hypertension. They therefore suggest that the terms Banti's disease and splenic anemia be replaced by congestive splenomegaly, as originally suggested by Larrabee. The type of liver cirrhosis in prolonged schistosomiasis results in the greatest increase in portal pressure and the largest spleens. The behavior of this parasitic disease is ideal for the production of portal hypertension. Campbell,9 on the basis of his extensive experience with schistosomiasis in the Orient, expresses the belief that most of the so-called Banti's disease of the Orient is actually schistosomiasis. He considers it probable that the disease as originally described by Banti might be schistosomiasis because of the proximity of Italy to Egypt, where the "Egyptian splenomegaly" has come to be recognized as schistosomial in origin.
+* Thompson explained similarities in the microscopic pathology of spleen in patients with Banti's syndrome, characterized by:
+** Variable degrees of follicular atrophy
+** Fibrosis of the white pulp
+** Dilated venous sinuses
+** Perifollicular hemorrhages
+* He described the obstructive lesions as being either intrahepatic or extrahepatic.
+** The intrahepatic lesion was defined to be cirrhosis and contained 68% of the cases that has undergone splenectomy.
+* Thompson and his associates shave made observations on the splenic vein pressure in fifteen cases in the course of operation by inserting the needle of the venous pressure apparatus into the splenic vein. The relatively great increase in splenic pressure in cases of Banti's syndrome when compared with the venous pressure simultaneously recorded in the arm suggests that portal hypertension is an important factor in the production of the chronic splenomegaly. The contention of the workers of the Combined Spleen Clinic is that Banti's disease or splenic anemia is a secondary mechanical manifestation of any of a variety of lesions producing chronic splenic vein hypertension. They therefore suggest that the terms Banti's disease and splenic anemia be replaced by congestive splenomegaly, as originally suggested by Larrabee. The type of liver cirrhosis in prolonged schistosomiasis results in the greatest increase in portal pressure and the largest spleens. The behavior of this parasitic disease is ideal for the production of portal hypertension.
+* Campbell was working on cases with schistosomiasis in the Orient. He described schistosomiasis as the main cause of the manifestations of Banti's syndrome. He believed that as most of the cases were observed by Banti in Italy, and based on the geographical proximity of Italy to Egypt which is considered as high prevalent area for schistosomiasis , probably the schistasomiasis is the main reason of the disease.
 <br />

Banti's syndrome: Difference between revisions

Revision as of 23:02, 28 January 2020

Overview

Historical Perspective

Navigation menu